| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |